Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs

BACKGROUND: Long-term monotherapy with nucleos(t)ide analogs (NAs) represents the treatment option for the majority of patients with chronic hepatitis B (CHB), an aging population with a greater likelihood of comorbidities. We assessed the prevalence of concurrent non-hepatic diseases and the safety...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Gastroenterol
Egile Nagusiak: Siakavellas, Spyros, Goulis, John, Manolakopoulos, Spilios, Triantos, Christos, Gatselis, Nikolaos, Tsentemidou, Eva, Kranidioti, Hariklia, Ζisimopoulos, Κonstantinos, Τsoulas, Christos, Dalekos, George, Papatheodoridis, George
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hellenic Society of Gastroenterology 2021
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7774663/
https://ncbi.nlm.nih.gov/pubmed/33414625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2020.0525
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak